AAAAAA

   
Results: 1-19 |
Results: 19
Opportunistic infections in persons with HIV or other immunocompromising conditions
Authors: Kaplan, JE Sepkowitz, K Masur, H Sirisanthana, T Russo, M Chapman, L
Citation: Je. Kaplan et al., Opportunistic infections in persons with HIV or other immunocompromising conditions, EM INFECT D, 7(3), 2001, pp. 541-541
Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: Impact on risk for infectious diseases
Authors: Dworkin, MS Williamson, J Jones, JL Kaplan, JE
Citation: Ms. Dworkin et al., Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: Impact on risk for infectious diseases, CLIN INF D, 33(3), 2001, pp. 393-398
Pneumococcal disease among human immunodeficiency virus-infected persons: Incidence, risk factors, and impact of vaccination
Authors: Dworkin, MS Ward, JW Hanson, DL Jones, JL Kaplan, JE
Citation: Ms. Dworkin et al., Pneumococcal disease among human immunodeficiency virus-infected persons: Incidence, risk factors, and impact of vaccination, CLIN INF D, 32(5), 2001, pp. 794-800
Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents
Authors: Kaplan, JE Hanson, DL Jones, JL Dworkin, MS
Citation: Je. Kaplan et al., Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents, AIDS, 15(14), 2001, pp. 1831-1836
Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients - Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplation
Authors: Dykewicz, CA Jaffe, HW Kaplan, JE
Citation: Ca. Dykewicz et al., Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients - Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplation, BIOL BLOOD, 6(6A), 2000, pp. 659
Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection
Authors: Cohn, DL O'Brien, RJ Geiter, LJ Gordin, FM Hershfield, E Horsburgh, CR Jereb, JA Jordan, TJ Kaplan, JE Nolan, CM Starke, JR Taylor, Z Villarino, ME Binkin, NJ Bock, NN Castro, KG Chaisson, RE Comstock, RE Dworkin, MS El-Sadr, W Fujiwara, PI Glassroth, JC Godfrey-Faussett, P Goldberger, MJ Hadler, JL Hopewell, PC Iseman, MD Jacobs, RF Land, MA Lobato, MN Menzies, RI Migliori, GB Miller, BI Mwinga, A Nardell, EA Neaton, J Qualls, NL Reichman, LB Rose, DN Salpeter, SR Sawert, H Simone, PM Snider, DE Tsevat, J Vernon, AA Whalen, CC Wilcosky, TC
Citation: Dl. Cohn et al., Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection, AM J R CRIT, 161(4), 2000, pp. S221-S247
Protists as opportunistic pathogens: Public health impact in the 1990s andbeyond
Authors: Kaplan, JE Jones, JL Dykewicz, CA
Citation: Je. Kaplan et al., Protists as opportunistic pathogens: Public health impact in the 1990s andbeyond, J EUKAR MIC, 47(1), 2000, pp. 15-20
Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Holmes, KK Kaplan, JE
Citation: H. Masur et al., Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S1-S4
Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy
Authors: Kaplan, JE Hanson, D Dworkin, MS Frederick, T Bertolli, J Lindegren, ML Holmberg, S Jones, JL
Citation: Je. Kaplan et al., Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy, CLIN INF D, 30, 2000, pp. S5-S14
An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons
Authors: Kaplan, JE Masur, H Holmes, KK Freedberg, KA Holtgrave, D Piscitelli, SC Van Dyke, R Watts, H
Citation: Je. Kaplan et al., An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons, CLIN INF D, 30, 2000, pp. S15-S28
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+T-lymphocyte counts of more than 500 x 10(6) cells/l
Authors: Chapman, LE Green, TA Ahmed, F Parekh, BS Rimland, D Kaplan, JE Thompson, MA Folks, TM
Citation: Le. Chapman et al., Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+T-lymphocyte counts of more than 500 x 10(6) cells/l, AIDS, 14(9), 2000, pp. 1135-1146
Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4(+) T lymphocyte counts above prophylaxis thresholds
Authors: Dworkin, MS Hanson, DL Kaplan, JE Jones, JL Ward, JW
Citation: Ms. Dworkin et al., Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4(+) T lymphocyte counts above prophylaxis thresholds, J INFEC DIS, 182(2), 2000, pp. 611-615
Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus
Authors: Navin, TR Rimland, D Lennox, JL Jernigan, J Cetron, M Hightower, A Roberts, JM Kaplan, JE
Citation: Tr. Navin et al., Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus, J INFEC DIS, 181(1), 2000, pp. 158-164
Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States
Authors: Kaplan, JE Parham, DL Soto-Torres, L van Dyck, K Greaves, JA Rauch, K Ellis, B Amandus, HE
Citation: Je. Kaplan et al., Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States, J ACQ IMM D, 21(3), 1999, pp. 228-235
Do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease? Editorial response
Authors: Kaplan, JE Janoff, EN Masur, H
Citation: Je. Kaplan et al., Do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease? Editorial response, CLIN INF D, 29(3), 1999, pp. 544-546
Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama
Authors: Maloney, EM Armien, B Gracia, F Castillo, L Kruger, H Levin, A Levine, PH Kaplan, JE Blattner, WA Giusti, RM
Citation: Em. Maloney et al., Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama, J INFEC DIS, 180(3), 1999, pp. 876-879
Surveillance for AIDS-defining opportunistic illnesses, 1992-1997
Authors: Jones, JL Hanson, DL Dworkin, MS Alderton, DL Fleming, PL Kaplan, JE Ward, J
Citation: Jl. Jones et al., Surveillance for AIDS-defining opportunistic illnesses, 1992-1997, ARCH DERMAT, 135(8), 1999, pp. 897-902
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908
Risultati: 1-19 |